SCHEMBL20174272

SCHEMBL20174272

c1ccc2c(c1)-c1ccccc1C21c2cc(-c3nc(-c4ccncc4)nc(-c4ccncc4)n3)ccc2-c2oc3ccccc3c21

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 2/20 0.39
PDK2 Q15119 1/20 0.38
MAPT P10636 7/20 0.37
ALDH1A1 P00352 6/20 0.37
KDM4E B2RXH2 5/20 0.37
LMNA P02545 5/20 0.37
HPGD P15428 5/20 0.37
SMN1; SMN2 Q16637 4/20 0.37
HSD17B10 Q99714 3/20 0.37
NPC1 O15118 3/20 0.37
RAB9A P51151 3/20 0.37
MAPK1 P28482 2/20 0.37
S1PR1 P21453 1/20 0.32
S1PR3 Q99500 1/20 0.32
KMT2A Q03164 3/20 0.31
TSHR P16473 2/20 0.31
MEN1 O00255 2/20 0.31
USP2 O75604 1/20 0.31
HTT P42858 1/20 0.31
POLB P06746 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20174200 0.92 MAPT (0.34) PDK2MAPTALDH1A1KDM4ELMNA
SCHEMBL20174211 0.91 PDK2 (0.34) PDK2MAPTALDH1A1KDM4ELMNA
SCHEMBL20174296 0.91 PDK2 (0.46) MAPK14PDK2MAPTALDH1A1KDM4E
SCHEMBL22326557 0.89 PDK2 (0.36) PDK2MAPTALDH1A1KDM4ELMNA
SCHEMBL20174273 0.89 PDK2 (0.36) PDK2MAPTALDH1A1KDM4ELMNA
SCHEMBL20174713 0.88 PIM1 (0.33) MAPTALDH1A1KDM4ELMNASMN1; SMN2
SCHEMBL20174205 0.87 ALOX5 (0.32) PDK2MAPTALDH1A1KDM4ELMNA
SCHEMBL20174225 0.87 KMT2A (0.37) PDK2MAPTALDH1A1KDM4ELMNA
SCHEMBL20174718 0.87 SMN1; SMN2 (0.38) MAPK14PDK2MAPTALDH1A1KDM4E
SCHEMBL20174198 0.85 KMT2A (0.36) PDK2MAPTALDH1A1KDM4ELMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10738034-B2 Spiro compound and organic light-emitting device comprising same LG CHEM, LTD. (KR) 2020-08-11 US disclosed
US-20180141933-A1 SPIRO COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LG CHEM, LTD. (KR) 2018-05-24 US disclosed
US-20180141933-A1 SPIRO COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LG CHEM, LTD. (KR) 2018-05-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10738034-B2 Spiro compound and organic light-emitting device comprising same CRY1, NR2E3, ERG MAPK14 3746/4885PDK2 651/4885MAPT 811/4885
US-20180141933-A1 SPIRO COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME CRY1, NR2E3, ERG MAPK14 3746/4885PDK2 651/4885MAPT 811/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.